Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Landos Biopharma
1800 Kraft Drive, Suite 216
Blacksburg, VA 24060
http://landosbiopharma.com/

Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos' lead clinical asset, BT-11, is a first-in-class, oral therapeutic that acts locally in the gastrointestinal tract for treatment of inflammatory bowel disease (IBD). The company has completed Phase 1 clinical testing and has initiated Phase 2 clinical testing of BT-11 for inflammatory bowel disease in 2019. Landos also has a robust pipeline of new compounds for other autoimmune diseases, several of which Landos anticipates will advance to IND and Phase 1 clinical testing in 2020.

Key Contact
NameTitleE-Mail
Dr. Josep Bassaganya-RieraPresident & CEOjbr@landosbiopharma.com


Funding Events
DateAmountTypeInvestors
08/13/19$60,000,000Series B Osage University Partners
PBM Capital Group
Perceptive Advisors  
RTW Investments  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.